RINVOQ® Receives Health Canada Notice of Compliance for Giant Cell Arteritis in adults Pharmaceutical Investing
BioLite, Inc., an ABVC BioPharma Subsidiary, Receives $230,000 Milestone Payment from AiBtl, Advancing Botanical Drug Licensing Collaboration Pharmaceutical Investing
BriaCell's Bria-OTS+ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal Biotech Investing
AbbVie to Acquire Gilgamesh Pharmaceuticals' Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline Pharmaceutical Investing
I-Mab Announces the Appointment of Seasoned Biotech Executives to the Board of Directors and the Scientific Advisory Board, and the Formation of a Research and Development Committee Pharmaceutical Investing
ABVC BioPharma Receives $100,000 Milestone Payment From ForSeeCon, Strengthening Vitargus Licensing Deal Pharmaceutical Investing
AbbVie Announces Positive Topline Results from Second Phase 3 UP-AA Trial Evaluating Upadacitinib for Alopecia Areata Pharmaceutical Investing
